Physician profile
Richard Munoz
NPI 1588691059
$3,010.72
in general payments reported to CMS, 2019-2025
21 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $144 · 2021: $635 · 2022: $1,077 · 2023: $338 · 2024: $292 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,587.48 | 2021-2025 | |
| Horizon Therapeutics Plc | $421.78 | 2019-2021 | |
| Kerecis Limited | $194.28 | 2020-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Nevro Corp. | $165.85 | 2023-2024 | Senza |
| Organogenesis INC. | $143.44 | 2021-2024 | |
| Stryker Corporation | $124.57 | 2019-2023 | Augment Injectable |
| Boston Scientific Corporation | $50.11 | 2019-2020 | |
| Bioventus LLC | $41.90 | 2025 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $39.79 | 2024-2025 | Nuzyra |
| Paragon 28, INC. | $34.59 | 2019-2024 | Phantom Intramedullary Nail |
| Kowa Pharmaceuticals America, INC. | $30.70 | 2023 | Seglentis |
| Globus Medical, INC. | $25.43 | 2025 | Senza |
| Zimmer Biomet Holdings, INC. | $22.37 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.22 | 2022 | |
| Amgen INC. | $17.60 | 2024 | Krystexxa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $16.94 | 2025 | Minibunion, N/A |
| Convatec INC. | $16.46 | 2023 | |
| Orthofix Medical, INC. | $15.22 | 2025 | Physio-Stim |
| Misonix INC | $15.21 | 2019 | |
| Smith+Nephew, INC. | $15.00 | 2019 | |
| Alfasigma USA, INC. | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.